Design of diastereomeric salt resolution multicomponent system characterization: a case study with hydrate formation
Diastereomeric salt crystallization is a convenient method to resolve chiral drug substances when other separation methods like preferential crystallization and solid-state deracemization cannot be applied directly. This is the case of the antiepileptic pregabalin, which is a racemate-forming compou...
Saved in:
Published in | CrystEngComm Vol. 25; no. 4; pp. 641 - 652 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Published |
23.01.2023
|
Online Access | Get full text |
Cover
Loading…
Summary: | Diastereomeric salt crystallization is a convenient method to resolve chiral drug substances when other separation methods like preferential crystallization and solid-state deracemization cannot be applied directly. This is the case of the antiepileptic pregabalin, which is a racemate-forming compound with recently discovered hydrate-forming activity. In this study, the quaternary system of pregabalin enantiomers,
l
-tartaric acid and water was investigated by the characterization of relevant solid forms and the measurement of solubilities and solid-liquid equilibria. This information was used to outline phase diagrams in the specific quaternary space and create a thermodynamic model based on solubility product constants to simulate the effect of variable parameters on the resolution process. Thus, a set of optimal temperature pairs were identified with similar selectivity along the so-called purity line in the region of 10-40 °C. This line was adjusted experimentally, and a realistic correction of 3 °C was made. Our method provided a quick process with low material requirements to design diastereomeric salt resolution. Finally, a proof of concept resolution experiment was conducted, where a diastereomerically pure product was obtained with 51.6% yield and 153 mg (g water)
−1
productivity.
Design of a chiral resolution process with thermodynamic control. |
---|---|
Bibliography: | Electronic supplementary information (ESI) available. CCDC For ESI and crystallographic data in CIF or other electronic format see DOI https://doi.org/10.1039/d2ce01490d 2215531 |
ISSN: | 1466-8033 |
DOI: | 10.1039/d2ce01490d |